Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Eckuity Capital is a healthcare-focused growth equity firm founded in 2021 and based in New York, USA. The firm was established by a team of experienced investors and life sciences executives with a mission to invest in established companies that demonstrate regulatory approval and commercial traction. Eckuity Capital partners with management teams to support disciplined growth and long-term value creation.
As of now, Eckuity Capital manages a fund size of $155 million and has a portfolio of nine companies. The firm has expanded its presence with an additional office in London, UK, allowing it to tap into both North American and European markets. The team comprises professionals with extensive backgrounds in healthcare investing and operations, enabling them to provide valuable insights and support to their portfolio companies.
Notable milestones include the successful closing of their first fund, Eckuity Capital Fund I, LP, which was announced in March 2024. The firm emphasizes a commitment to enhancing commercial execution and organizational development within its portfolio, aiming to drive growth and long-term success.
Eckuity Capital specializes in growth equity investments within the healthcare sector, specifically targeting established companies that exhibit clinical relevance and durable market positions. The firm focuses on late-stage venture opportunities, particularly in MedTech, HealthTech, and Biotech Services. Their investment strategy emphasizes capital efficiency, operational scalability, and multiple paths to liquidity.
The firm seeks companies with regulatory approval, commercial traction, and scalable operating models. Eckuity Capital aims to support portfolio companies through strategic planning, commercial execution, and organizational development. They look for management teams that demonstrate a clear vision and the ability to execute on their strategic goals, ensuring alignment with Eckuity's focus on disciplined growth.
Eckuity Capital's portfolio consists of nine companies across the healthcare sector, showcasing their commitment to supporting innovative solutions. Notable portfolio companies include:
This diverse portfolio reflects Eckuity Capital's focus on companies that have achieved regulatory approval and demonstrate commercial traction, positioning them for growth in the healthcare market.
Youssef Sebban - Managing Partner; co-founder with extensive experience in healthcare investing and portfolio development.
Dr. Victoria Manax Rutson, MD - General Partner; brings a background in oncology and was appointed in March 2024.
Karim Maasarani - General Partner; focuses on investment strategy and execution.
Dr. Michael Salako, PhD - Principal; specializes in life sciences and healthcare investments.
Allison Hood - Investment Associate; supports deal sourcing and portfolio management.
Waez Umer, MD - Investment Analyst; conducts market research and analysis for potential investments.
Ryan Green - COO & Head of Investor Relations; oversees operations and investor communications.
Jonny He - CFO; manages financial strategy and fund operations.
Elaine Pang - Head of Portfolio Operations; focuses on enhancing operational efficiency within portfolio companies.
Peter Cicala - Legal Advisor; provides legal guidance on investment transactions and compliance.
To pitch Eckuity Capital, founders should send an email to info@eckuity.com. A comprehensive pitch deck is recommended, including details about the business model, market opportunity, competitive landscape, and team background. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
In March 2024, Eckuity Capital announced the closing of its first fund, Eckuity Capital Fund I, LP, with a total size of $155 million. This fund focuses on growth equity investments in established healthcare companies.
In April 2024, Eckuity Capital invested in Avive Solutions, a MedTech company known for its next-generation automated external defibrillator (AED) aimed at improving survival rates from sudden cardiac arrest.
In May 2025, Eckuity Capital announced a partnership with Huma Therapeutics to accelerate M&A activities, further expanding their investment strategy beyond direct equity investments.
What are Eckuity Capital's investment criteria?
Eckuity Capital targets established healthcare companies that have regulatory approval, commercial traction, and scalable operating models. They focus on late-stage venture opportunities and growth equity investments.
How can I pitch to Eckuity Capital?
Founders can reach out via email at info@eckuity.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes Eckuity Capital different from other investors?
Eckuity Capital emphasizes a hands-on approach, providing strategic guidance and operational support to its portfolio companies. Their team has extensive experience in healthcare investing, which allows them to add significant value beyond capital.
What is the geographic scope of Eckuity Capital's investments?
The firm primarily focuses on North America, particularly the United States, but also has a presence in Europe through its London office.
What is the typical check size for investments?
While specific check sizes are not disclosed, Eckuity Capital focuses on growth equity investments, which typically involve larger amounts than early-stage funding.
What kind of support can portfolio companies expect?
Eckuity Capital provides operational support, strategic guidance, and access to a network of industry experts to help portfolio companies achieve their growth objectives.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.